Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort
© 2021 S. Karger AG, Basel..
BACKGROUND: There is growing evidence of gender-specific phenotypic differences among patients with idiopathic pulmonary fibrosis (IPF), which may affect patient outcomes.
OBJECTIVES: We present the characteristics of patients with IPF at inclusion in the French Rare Disease Cohort - Interstitial Lung Disease (RaDiCo-ILD) with the aim of characterizing gender-specific phenotypic differences.
METHODS: Patients with IPF who were enrolled in the national, multicentre RaDiCo-ILD cohort were included. Demographic characteristics, comorbidities, health-related quality of life (HRQoL) scores, pulmonary function, chest imaging, and IPF treatment were collected at inclusion and described by gender.
RESULTS: The cohort included 724 patients with IPF (54% of RaDiCo-ILD cohort), of whom 82.9% were male. The proportion of male and female patients with a prior history of smoking was 75.0% and 26.8%, respectively. Emphysema was present in 17.0% (95% confidence interval [CI]: 10.0, 24.0) of men and 5.4% (95% CI: 1.2, 9.6) of women. At inclusion, females had poorer HRQoL than males based on St. George's Respiratory Questionnaire scores (48.5 [95% CI: 43.9, 53.0] and 41.5 [39.4, 43.6], respectively). The mean forced vital capacity per cent predicted was 77.7% (95% CI: 76.2, 79.3) and 87.4% (83.4, 91.4) for males and females, respectively. Honeycombing on high-resolution computed tomography (HRCT) was present in 70.8% (95% CI: 61.0, 80.6) of males and 45.8% (95% CI: 35.1, 56.5) of females.
CONCLUSIONS: This analysis of patients with IPF at inclusion in the RaDiCo-ILD cohort provides evidence that comorbid emphysema, lung volume reduction, and honeycombing on HRCT are more common characteristics of males than females.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Respiration; international review of thoracic diseases - 101(2022), 1 vom: 31., Seite 34-45 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cottin, Vincent [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
France |
|---|
| Anmerkungen: |
Date Completed 16.05.2022 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1159/000518008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330573969 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330573969 | ||
| 003 | DE-627 | ||
| 005 | 20231225211557.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000518008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330573969 | ||
| 035 | |a (NLM)34515219 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cottin, Vincent |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.05.2022 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 S. Karger AG, Basel. | ||
| 520 | |a BACKGROUND: There is growing evidence of gender-specific phenotypic differences among patients with idiopathic pulmonary fibrosis (IPF), which may affect patient outcomes | ||
| 520 | |a OBJECTIVES: We present the characteristics of patients with IPF at inclusion in the French Rare Disease Cohort - Interstitial Lung Disease (RaDiCo-ILD) with the aim of characterizing gender-specific phenotypic differences | ||
| 520 | |a METHODS: Patients with IPF who were enrolled in the national, multicentre RaDiCo-ILD cohort were included. Demographic characteristics, comorbidities, health-related quality of life (HRQoL) scores, pulmonary function, chest imaging, and IPF treatment were collected at inclusion and described by gender | ||
| 520 | |a RESULTS: The cohort included 724 patients with IPF (54% of RaDiCo-ILD cohort), of whom 82.9% were male. The proportion of male and female patients with a prior history of smoking was 75.0% and 26.8%, respectively. Emphysema was present in 17.0% (95% confidence interval [CI]: 10.0, 24.0) of men and 5.4% (95% CI: 1.2, 9.6) of women. At inclusion, females had poorer HRQoL than males based on St. George's Respiratory Questionnaire scores (48.5 [95% CI: 43.9, 53.0] and 41.5 [39.4, 43.6], respectively). The mean forced vital capacity per cent predicted was 77.7% (95% CI: 76.2, 79.3) and 87.4% (83.4, 91.4) for males and females, respectively. Honeycombing on high-resolution computed tomography (HRCT) was present in 70.8% (95% CI: 61.0, 80.6) of males and 45.8% (95% CI: 35.1, 56.5) of females | ||
| 520 | |a CONCLUSIONS: This analysis of patients with IPF at inclusion in the RaDiCo-ILD cohort provides evidence that comorbid emphysema, lung volume reduction, and honeycombing on HRCT are more common characteristics of males than females | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a France | |
| 650 | 4 | |a Gender | |
| 650 | 4 | |a Idiopathic interstitial pneumonia | |
| 650 | 4 | |a Idiopathic pulmonary fibrosis | |
| 650 | 4 | |a Patient characteristics | |
| 650 | 4 | |a Registry | |
| 700 | 1 | |a Gueguen, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Jouneau, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Nunes, Hilario |e verfasserin |4 aut | |
| 700 | 1 | |a Crestani, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Bonniaud, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Wémeau-Stervinou, Lidwine |e verfasserin |4 aut | |
| 700 | 1 | |a Reynaud-Gaubert, Martine |e verfasserin |4 aut | |
| 700 | 1 | |a Israël-Biet, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Cadranel, Jacques |e verfasserin |4 aut | |
| 700 | 1 | |a Marchand-Adam, Sylvain |e verfasserin |4 aut | |
| 700 | 1 | |a Quétant, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Hirschi, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Montani, David |e verfasserin |4 aut | |
| 700 | 1 | |a Gamez, Anne-Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Chevereau, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Dufaure-Garé, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Amselem, Serge |e verfasserin |4 aut | |
| 700 | 1 | |a Clement, Annick |e verfasserin |4 aut | |
| 700 | 0 | |a OrphaLung and RespiFil Networks |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiration; international review of thoracic diseases |d 1968 |g 101(2022), 1 vom: 31., Seite 34-45 |w (DE-627)NLM000076384 |x 1423-0356 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2022 |g number:1 |g day:31 |g pages:34-45 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000518008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2022 |e 1 |b 31 |h 34-45 | ||